ADDvise receives frame agreement from SLL at an order value of 20 + 20 MSEK

10-01-2017   Regulatory press release

IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement for laparoscopy products from the County Council of Stockholm. The estimated value of the agreement for IM-Medico is 10 MSEK per annum. The agreement runs for two years with a two-year prolongation option.

IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement from the County Council of Stockholm for laparoscopy products. These products are used in laparoscopy procedures with internal stapling for invasive surgery. IM-Medico has been chosen as the preferred supplier in competition with vendors such as Johnsson & Johnsson and Medtronic.

-       Rikard Akhtarzand comments the business; “Our extensive investment in the surgery segment is now paying off. To be chosen as the preferred supplier in competition with Johnsson & Johnsson and Medtronic is a major achievement for us”.

The agreement has a standstill period until January 19 2017 and starts running on June 1 2017.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se 


Important information:
 

This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 10, 2017 at 08:45 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com

Latest press releases

ADDvise receives order from Cadwell Industries worth approximately USD 1.7 million

Regulatory

ADDvise Group AB’s subsidiary Merit Cables Inc has received an order from Cadwell Industries, a company specialized in electrodes, consumables, supplies, and accessories for neurology, worth approximately USD 1.7 million. The order involves wires for electrodiagnostic supplies such as EEG, EMG and ultrasound for measuring and evaluating electrical brain and muscle activity. Delivery of the…

ADDvise acquires Seebreath AB

Regulatory

ADDvise Group AB has today entered into a share purchase agreement with the owners of Seebreath AB (“Seebreath”) regarding the acquisition of all the outstanding shares of Seebreath. The acquisition is in line with the letter of intent communicated via a press release dated February 28, 2022. Closing of the acquisition takes place today. Seebreath’s…

Interim report January 1 – March 31 2022

Regulatory

January-March 2022 Net revenue for the period was SEK 162.4 million (87.7), an increase of 85.1 %. Organic growth was 4.2 %. Adjusted EBITDA for the period was SEK 21.3 million (8.0) EBITDA for the period was SEK 21.2 million (8.9) Adjusted profit/loss for the period was SEK 5.8 million (1.6) Basic earnings per share…